Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Oncogene|September 13, 2005
Viruses with deletions in antiapoptotic genes as potential oncolytic agentsTa-Chiang Liu, David KirnCancer Research|January 20, 2007
Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directionsTa-Chiang Liu, David KirnCancer Gene Therapy|January 11, 2003
The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to considerRichard Vile, Dale Ando, David KirnCancer Gene Therapy|January 11, 2003
Intravascular adenoviral agents in cancer patients: lessons from clinical trialsTony Reid, Robert Warren, David KirnSeminars in Oncology|December 13, 2005
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effectsStephen H Thorne, Terry Hermiston, David KirnNature Clinical Practice. Oncology|January 30, 2007
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progressTa-Chiang Liu, Evanthia Galanis, David KirnThe Lancet. Oncology|March 22, 2002
Oncolytic biotherapy: a novel therapeutic plafformLynda K Hawkins, Nick R Lemoine, David KirnTrends in Molecular Medicine|April 3, 2002
The emerging fields of suicide gene therapy and virotherapyDavid Kirn, Ion Niculescu-Duvaz, Gunnel Hallden, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinomaStephen Morley, Gordon MacDonald, David Kirn, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potencyTa-Chiang Liu, Gunnel Hallden, Yaohe Wang, et al.Pageof 3